1. Expression of VHL tumor suppressor mRNA and miR-92a in papillary thyroid carcinoma and their correlation with clinical and pathological parameters

   • Lidija Todorović
   • Boban Stanojević
   • Shunichi Yamashita

   Original Paper 16 January 2018 Article: 17

   

2. Genetic polymorphisms associated with adverse reactions of molecular-targeted therapies in renal cell carcinoma

   • Kazuhiro Yamamoto
   • Ikuko Yano

   Review Article 04 January 2018 Article: 16

3. First-line treatment with bendamustine and rituximab, in patients with intermediate-/high-risk splenic marginal zone lymphomas

   • Roberto Castelli
   • Luigi Bergamaschini
   • Giorgio Lambertenghi Deliliers

   Short Communication 29 December 2017 Article: 15